Ledger.Open graph →
SEC Form D · filed December 13, 2018

Viracta Therapeutics, INC

Offering
$10.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cardiff, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

David Slack · Cardiff, CAExecStandish Fleming · Cardiff, CADirectorBarry Simon · Cardiff, CADirectorIvor Royston · Cardiff, CAExec · DirectorPatrick Soon-Shiong · Cardiff, CADirectorJames Woody · Cardiff, CADirectorRichard Ghalie · Cardiff, CADirectorTerrence D. Yodaiken · London, United KingdomDirectorClare F. Wood · London, United KingdomDirectorKripa Varanasi · WOBURN, MADirectorSamuel Sichko · WOBURN, MADirectorMark Little · WOBURN, MADirectorRajesh Unni · WOBURN, MAExec · DirectorBritta P. Mccorduck · Charlotte, NCExecFernando C. Verboonen · Rio de Janeiro, GuernseyDirectorWolney C. Betiol · Rio de Janeiro, GuernseyExecNelson Abrahao · Rio de Janeiro, GuernseyDirectorKen T. Denman · La Jolla, CAExec · DirectorLegendary Lodging VAB QOZ Manager, LLC · Fargo, NDDirectorAllen Faires · Columbus, OHDirectorAnthony Meyer · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗